Smooth muscle cells of human intracranial aneurysms assume phenotypic features similar to those of the atherosclerotic plaque.

OBJECTIVES Characterize the phenotypic features of smooth muscle cells (SMCs) in the wall of human saccular intracranial aneurysms (sIAs). METHODS AND RESULTS We investigated by means of immunohistochemistry the expression of the cytoskeletal differentiation markers α-smooth muscle actin (α-SMA), smooth muscle myosin heavy chains (SMMHCs), and smoothelin in 26 sIAs and 15 nonaneurysmal cerebral arteries. In addition, S100A4, a recently identified marker of dedifferentiated SMCs in atherosclerotic plaques, was also investigated. Six sIAs and 5 nonaneurysmal arteries were used for morphometric analysis. sIAs displayed a significant medial atrophy compared with nonaneurysmal cerebral arteries; moreover, sIA SMCs showed marked decrease of α-SMA and SMMHCs expression and disappearance of smoothelin. Unexpectedly, S100A4 was strongly up-regulated in media SMCs of sIAs. CONCLUSIONS In sIAs, media SMCs acquire a dedifferentiated phenotype and show de novo expression of S100A4, characteristic features of atherosclerotic plaque SMCs.

[1]  Y. Ushio,et al.  Differential distribution and expressions of collagens in the cerebral aneurysmal wall , 1997, Acta Neuropathologica.

[2]  I. Sibon,et al.  Association between semicarbazide-sensitive amine oxidase, a regulator of the glucose transporter, and elastic lamellae thinning during experimental cerebral aneurysm development: laboratory investigation. , 2008, Journal of neurosurgery.

[3]  Paula Clancy,et al.  Association Between Osteopontin and Human Abdominal Aortic Aneurysm , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[4]  M. Bacchetta,et al.  Intimal Smooth Muscle Cells of Porcine and Human Coronary Artery Express S100A4, a Marker of the Rhomboid Phenotype In Vitro , 2007, Circulation research.

[5]  Mohammad Saleem,et al.  S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9 , 2006, Proceedings of the National Academy of Sciences.

[6]  D. Helfman,et al.  The metastasis associated protein S100A4: role in tumour progression and metastasis , 2005, British Journal of Cancer.

[7]  M. Andréani,et al.  Semicarbazide‐Sensitive Amine Oxidase in Vascular Smooth Muscle Cells: Differentiation‐Dependent Expression and Role in Glucose Uptake , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[8]  S. P. Walton,et al.  Smooth muscle phenotypic modulation is an early event in aortic aneurysms. , 2009, The Journal of thoracic and cardiovascular surgery.

[9]  M. Klapholz,et al.  Osteopontin in Cardiovascular Disease: A Potential Therapeutic Target , 2010, Cardiology in review.

[10]  I. Awad,et al.  Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. , 1996, Neurosurgery.

[11]  R. Virmani,et al.  Phenotypic Modulation of Intima and Media Smooth Muscle Cells in Fatal Cases of Coronary Artery Lesion , 2005 .

[12]  M. Günel,et al.  Expression of Structural Proteins and Angiogenic Factors in Normal Arterial and Unruptured and Ruptured Aneurysm Walls , 2005, Neurosurgery.

[13]  D. Milewicz,et al.  TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. , 2010, Cardiovascular research.

[14]  S. Hirota,et al.  Alpha actin isoforms expression in human and rat adult cardiac conduction system. , 2009, Differentiation; research in biological diversity.

[15]  Julie H. Campbell,et al.  Extracellular Matrix‐Smooth Muscle Phenotype Modulation by Macrophages a , 1990, Annals of the New York Academy of Sciences.

[16]  J. Thyberg,et al.  Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study , 1995, Cell and Tissue Research.

[17]  G. V. van Eys,et al.  Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells , 1996, The Journal of cell biology.

[18]  T. Sano,et al.  Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls , 2000, Acta Neuropathologica.

[19]  M. Savolainen,et al.  Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms. , 2013, The Journal of thoracic and cardiovascular surgery.

[20]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[21]  M. Taneda,et al.  Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. , 1999, Stroke.

[22]  S. Clément,et al.  β- and γ-cytoplasmic actins display distinct distribution and functional diversity , 2009, Journal of Cell Science.

[23]  Aman B Patel,et al.  Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association , 1994, Stroke.

[24]  G. Mælandsmo,et al.  Osteopontin—An important downstream effector of S100A4‐mediated invasion and metastasis , 2011, International journal of cancer.

[25]  M. Piechota,et al.  Gene Expression Profiles in Human Ruptured and Unruptured Intracranial Aneurysms: What Is the Role of Inflammation? , 2010, Stroke.

[26]  A. Algra,et al.  Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis , 2011, The Lancet Neurology.

[27]  G. Gabbiani,et al.  A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation , 1986, The Journal of cell biology.

[28]  T. Kiehl,et al.  Intracranial aneurysms: from vessel wall pathology to therapeutic approach , 2011, Nature Reviews Neurology.

[29]  S. Mishra,et al.  S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence , 2011, Cancer and Metastasis Reviews.

[30]  M. Grigorian,et al.  Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity , 2004, Oncogene.

[31]  O. T. Odegaard,et al.  S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. , 1999, Cancer research.

[32]  A. Chiavegato,et al.  Molecular and cellular phenotypes and their regulation in smooth muscle. , 1999, Reviews of physiology, biochemistry and pharmacology.

[33]  W. Koch,et al.  Biology of Intracranial Aneurysms: Role of Inflammation , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  G. Owens,et al.  Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.

[35]  P. Doevendans,et al.  Regulation and characteristics of vascular smooth muscle cell phenotypic diversity , 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.